Denise Whitby

Author PubWeight™ 94.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 2006 4.13
2 Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis 2003 2.42
3 Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J Infect Dis 2007 2.17
4 No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS 2008 1.99
5 Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis 2007 1.88
6 Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis 2006 1.83
7 High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy. Blood 2011 1.81
8 Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology 2006 1.81
9 Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett 2011 1.71
10 An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis 2010 1.70
11 Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis 2004 1.64
12 Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis 2003 1.62
13 Host immunogenetics and control of human herpesvirus-8 infection. J Infect Dis 2006 1.52
14 Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda. J Acquir Immune Defic Syndr 2013 1.51
15 Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr 2005 1.51
16 Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 2003 1.49
17 Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection. Clin Vaccine Immunol 2009 1.45
18 Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004 1.32
19 Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J Virol 2005 1.30
20 Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer 2002 1.27
21 Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst 2003 1.26
22 Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis 2009 1.24
23 Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood 2013 1.23
24 Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr 2007 1.22
25 Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. J Infect Dis 2009 1.22
26 Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda. J Infect Dis 2004 1.21
27 Molecular evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus in Uganda and K1 gene evolution within the host. J Infect Dis 2006 1.21
28 Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008 1.21
29 Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria. AIDS 2002 1.17
30 Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma. Cancer 2006 1.17
31 Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily. Cancer Epidemiol Biomarkers Prev 2008 1.16
32 High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. J Infect Dis 2005 1.16
33 Azidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphoma. Blood 2005 1.14
34 Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G. J Clin Microbiol 2006 1.13
35 Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J Clin Oncol 2012 1.09
36 Detection of antibodies to Kaposi's sarcoma-associated herpesvirus: a new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA. J Immunol Methods 2010 1.09
37 Kaposi's sarcoma-associated herpesvirus transmission and primary infection. Curr Opin HIV AIDS 2009 1.08
38 A pilot study of cidofovir in patients with kaposi sarcoma. J Infect Dis 2002 1.07
39 Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia. Haematologica 2007 1.07
40 Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Am J Clin Pathol 2013 1.06
41 Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma. Transplantation 2008 1.06
42 Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study. Int J Cancer 2007 1.06
43 Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men. J Infect Dis 2002 1.06
44 Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology. Ann Epidemiol 2010 1.02
45 Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. AIDS 2003 1.00
46 Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus. Mod Pathol 2003 0.99
47 One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. Hum Genet 2007 0.98
48 Impact of interleukin-10 polymorphisms (-1082 and -3575) on the survival of patients with lymphoid neoplasms. Haematologica 2007 0.98
49 Combining assays for estimating prevalence of human herpesvirus 8 infection using multivariate mixture models. Biostatistics 2007 0.95
50 Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa. Infect Agent Cancer 2011 0.95
51 Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan. Int J Cancer 2006 0.93
52 Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity. Cancer Epidemiol Biomarkers Prev 2006 0.93
53 Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study. J Clin Virol 2006 0.93
54 Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt. Emerg Infect Dis 2008 0.92
55 Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers. Arch Dermatol 2005 0.91
56 Kaposi's sarcoma-associated herpesvirus microRNA single-nucleotide polymorphisms identified in clinical samples can affect microRNA processing, level of expression, and silencing activity. J Virol 2013 0.88
57 Human herpesvirus 8 (HHV-8) infection in healthy urban employees from Greece: seroprevalence and associated factors. J Med Virol 2007 0.87
58 Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens. Cancer Epidemiol Biomarkers Prev 2007 0.87
59 Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions. Cancer Lett 2008 0.87
60 Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa. Infect Agent Cancer 2010 0.86
61 Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study. J Infect Dis 2010 0.85
62 Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia. Sex Health 2005 0.85
63 Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome. J Infect Dis 2012 0.84
64 Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in Sicily. J Med Virol 2009 0.84
65 Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma. Int J Epidemiol 2005 0.83
66 Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients. AIDS 2004 0.83
67 Kaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adults. J Acquir Immune Defic Syndr 2013 0.82
68 Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy. AIDS 2015 0.81
69 Age of infection and risk of virally associated cancers: new clues to an old puzzle. J Infect Dis 2012 0.81
70 Human herpesvirus 8 seroprevalence among children and adolescents in the United States. Pediatr Infect Dis J 2008 0.81
71 Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York City. Int J Epidemiol 2002 0.80
72 Searching for targets of viral microRNAs. Nat Genet 2009 0.79
73 Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis. Semin Arthritis Rheum 2008 0.78
74 Prevalence and risk factors of human papillomavirus infection in asymptomatic women in a Venezuelan urban area. Invest Clin 2009 0.78
75 A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma. Cancer Epidemiol Biomarkers Prev 2005 0.78
76 Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study. Int J Cancer 2014 0.77
77 Viruses and kidney disease: beyond HIV. Semin Nephrol 2008 0.76
78 Serum cytokine analysis in a positive chemoprevention trial: selenium, interleukin-2, and an association with squamous preneoplastic disease. Cancer Prev Res (Phila) 2010 0.75
79 Quantitative determinations of anti-Kaposi sarcoma-associated herpesvirus antibody levels in men who have sex with men. Diagn Microbiol Infect Dis 2013 0.75
80 A Unique Case of Classic Kaposi's sarcoma restricted to the toes. J Dermatol Case Rep 2013 0.75
81 Human papillomavirus false positive cytological diagnosis in low grade squamous intraepithelial lesion. Invest Clin 2009 0.75
82 Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. Transplantation 2010 0.75